Table 1 Baseline criteria in the studied patients (n = 66)
From: Baseline vitamin D levels and functional outcome in thrombolyzed stroke patients
All patients n = 66 | Normal Vit. D n = 29 | Low Vit. D n = 37 | p value | |
|---|---|---|---|---|
Age (years) mean ± SD | 60.6 ± 10.2 | 56.6 ± 9.3 | 63.8 ± 9.9 | 0.003 |
BMI (Kg/m2) mean ± SD | 27.9 ± 3.4 | 28.3 ± 2.8 | 27.6 ± 3.8 | 0.38 |
Male/female n | 31/35 | 12/17 | 19/18 | 0.42 |
Risk factors n (%) | ||||
Diabetes | 26 (39.4) | 9 (31.0) | 17 (45.9) | 0.22 |
Hypertension | 37 (56.1) | 18 (62.1) | 19 (51.4) | 0.38 |
AF | 14 (21.2) | 6 (20.7) | 8 (21.6) | 0.93 |
Valvular heart disease | 26 (39.4) | 10 (34.5) | 16 (43.2) | 0.47 |
Smoking | 21 (31.8) | 10 (34.5) | 11 (29.7) | 0.68 |
Previous stroke | 7 (10.6) | – | 7 (18.9) | 0.013 |
Family history | 8 (12.1) | 3 (10.3) | 5 (13.5) | 0.7 |
NIHSS at onset | 12.0 ± 4.7 | 11.2 ± 4.4 | 12.6 ± 4.8 | 0.21 |
DNT (minutes) mean ± SD | 32.4 ± 8.2 | 34.0 ± 9.6 | 31.1 ± 6.8 | 0.17 |
TOAST classification n (%) | ||||
Cardio-embolic | 14 (21.2) | 8 (27.6) | 6 (16.2) | 0.64 |
Large artery disease | 20 (30.3) | 9 (31.0) | 11 (29.7) | |
Small vessel disease | 12 (18.2) | 5 (17.2) | 7 (18.9) | |
Undetermined | 20 (30.3) | 7 (24.1) | 13 (35.1) | |
Laboratory findings mean ± SD | ||||
Cholesterol mg/dL | 186.53 ± 30.44 | 179.72 ± 37.62 | 191.86 ± 22.5 | 0.11 |
TGs mg/dL | 132.50 ± 38.77 | 129.41 ± 32.94 | 134.91 ± 43.08 | 0.57 |
HDL-c mg/dL | 38.72 ± 7.17 | 40.03 ± 6.416 | 37.70 ± 7.64 | 0.19 |
Uric acid mg/dL | 5.15 ± 0.94 | 5.11 ± 0.99 | 5.18 ± 0.914 | 0.77 |
RBS mg/dL | 180.7 ± 52.7 | 192.1 ± 53.2 | 171.8 ± 51.3 | 0.12 |
Carotid artery atherosclerosis n (%) | ||||
Right | 41 (62.1) | 14 (48.3) | 27 (73.0) | 0.04 |
Left | 40 (60.6) | 15 (51.7) | 25 (67.6) | 0.19 |
Infarction size (cm3) mean ± SD | 4.8 ± 2.6 | 3.6 ± 2.1 | 5.6 ± 2.6 | 0.001 |